The Role of 3,5-Dibromopyrazin-2-amine in Pharmaceutical Intermediate Synthesis
The landscape of pharmaceutical development is constantly evolving, driven by the need for novel and effective therapeutic agents. Central to this progress is the availability of high-quality chemical intermediates that serve as the fundamental building blocks for complex drug molecules. Among these critical compounds, 3,5-Dibromopyrazin-2-amine (CAS: 24241-18-7) has emerged as a particularly valuable player.
3,5-Dibromopyrazin-2-amine, a derivative of pyrazine, is characterized by its specific arrangement of bromine atoms and an amino group. This unique structural configuration endows it with significant reactivity, making it an ideal precursor for a wide range of organic syntheses. In the pharmaceutical industry, its versatility is most evident in its application as a key intermediate for synthesizing active pharmaceutical ingredients (APIs).
Applications in Drug Discovery and Development:
Researchers widely utilize 3,5-Dibromopyrazin-2-amine in the development of various therapeutic classes. It has been identified as a crucial component in the synthesis of compounds exhibiting anticancer properties, targeting specific cellular pathways involved in tumor growth. Furthermore, its derivatives are being investigated for their potential as anti-inflammatory agents and treatments for cardiovascular disorders, including its role in developing rho kinase (ROCK) inhibitors.
The compound’s ability to undergo diverse chemical transformations, such as nucleophilic substitution reactions, allows chemists to introduce various functional groups, tailoring the final molecular structure for optimal pharmacological activity. This makes it an indispensable tool for medicinal chemists aiming to discover and optimize new drug candidates.
Sourcing High-Quality Intermediates:
For pharmaceutical companies, securing a consistent supply of high-purity 3,5-Dibromopyrazin-2-amine is essential for both research and development phases and eventual large-scale production. As a leading manufacturer and supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. specializes in providing this critical intermediate. We understand the exacting quality requirements of the pharmaceutical sector and are dedicated to delivering products that meet stringent purity specifications.
Our commitment extends to offering competitive pricing and reliable delivery, ensuring that your supply chain remains robust. By choosing NINGBO INNO PHARMCHEM, you gain a partner focused on supporting your drug discovery efforts with dependable chemical building blocks.
Whether you are involved in early-stage research or scaling up production, 3,5-Dibromopyrazin-2-amine offers significant advantages. We encourage you to explore its potential for your next pharmaceutical project and to consider NINGBO INNO PHARMCHEM as your trusted supplier.
Perspectives & Insights
Alpha Spark Labs
“It has been identified as a crucial component in the synthesis of compounds exhibiting anticancer properties, targeting specific cellular pathways involved in tumor growth.”
Future Pioneer 88
“Furthermore, its derivatives are being investigated for their potential as anti-inflammatory agents and treatments for cardiovascular disorders, including its role in developing rho kinase (ROCK) inhibitors.”
Core Explorer Pro
“The compound’s ability to undergo diverse chemical transformations, such as nucleophilic substitution reactions, allows chemists to introduce various functional groups, tailoring the final molecular structure for optimal pharmacological activity.”